therascreen KRAS RGQ PCR Kit
FDA-approved real-time PCR KRAS companion diagnostic for colorectal cancer.
- Developer
- QIAGEN
- Intended use
- Other
- Cancer scope
- Not reported
- Specimen
- FFPE tumor tissue
- Molecular modality
- DNA mutation
- Current version
- therascreen KRAS RGQ PCR Kit P110027/S018 current lineage
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.